SERIES A COMMON STOCK PURCHASE WARRANT hemispherx biopharma, inc.Hemispherx Biopharma Inc • June 1st, 2017 • Biological products, (no disgnostic substances)
THIS SERIES A COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after December [__, 2017 (the “Initial Exercise Date”) and on or prior to the close of business on March 6, 2022 (the “Termination Date”) but not thereafter, to subscribe for and purchase from Hemispherx BioPharma, Inc., a Delaware corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
Re: Reset Offer of Common Stock Purchase WarrantsHemispherx Biopharma Inc • June 1st, 2017 • Biological products, (no disgnostic substances)
We are pleased to offer to you the opportunity to reprice the exercise of all of the Common Stock Purchase Warrants originally issued to you on September 6, 2016 (the “September Warrants”) and currently held by you (“Holder”). The September Warrants, and the shares underlying the September Warrants (“Warrant Shares”) have been registered for sale pursuant to a registration statement on Form S-1 (File No. 333-217671) (the “Registration Statement”). The Registration Statement is currently effective and, upon exercise of the September Warrants pursuant to this letter agreement, will be effective for the issuance of the Warrant Shares. Capitalized terms not otherwise defined herein shall have the meanings set forth in the Securities Purchase Agreement, dated as of August 30, 2016, by and among the Company and the signatories thereto (the “Purchase Agreement”).
